Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.
about
The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issuesInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaKi-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is consideredDifferential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.Tgf-beta signaling pathway in lung adenocarcinoma invasion.An automated segmentation approach for highlighting the histological complexity of human lung cancerA grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.Prognosis and morphometrical features of non-bronchioloalveolar cell adenocarcinoma: an assessment of the non-alveolar replacing area and high grade atypical areaHistologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements.A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation.Naked cuticle Drosophila 1 expression in histologic subtypes of small adenocarcinoma of the lungPhase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphomaUpdate in lung cancer 2008Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.Expression of double-stranded RNA-activated protein kinase in small-size peripheral adenocarcinoma of the lung.Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma.
P2860
Q26864736-919AC98F-412E-475F-847A-EF7F384A1A25Q28303718-D1490E59-62ED-491F-99B1-EE11B8427E77Q33655228-5126D05C-6960-44DE-A8F5-EA3FA0905580Q33733522-6220D8FF-1B1A-4CA7-9920-229A9C650936Q34356297-E760A258-1D01-4F57-96F8-071425AD0D3DQ34374887-C4EA2CC6-54C6-49E2-915C-1DC965EC7994Q35245367-015E155C-4B6F-4AFC-AD41-EF67782DB081Q35769792-9A35C777-5EE7-4EF5-AB68-2522BAE941AAQ36013991-08310620-21BF-4B81-AB11-55EF2B3CC01FQ36324943-DB2F5D08-0AEB-4F87-AD7E-6AE23546F91AQ36636641-F7DEC45C-8C51-466A-B35B-293EF357DFBCQ36805435-EB75D1C9-2D4C-470B-AA20-B1E35ABD2F91Q36861021-71A4A491-EB70-45A4-95B6-9D3BD0087D1EQ36983401-69FC7D1F-5277-4037-B106-0B366D21E6B8Q37125103-FDB1CBB6-6F65-4193-AFDE-2E08594E09ACQ37220967-6ADAD819-2D2F-44C4-AC90-6FCF1EC04DF5Q37287067-FECA0114-D862-4B89-9D7C-22B896E0F0DFQ38317520-BD16F227-FF2E-49AF-97D7-1315A351C421Q39367391-1AD10D81-EAB5-41C2-980D-18514CF18F31Q39500296-0B32C58B-9E50-4FBD-874E-C683418D10B2Q44442401-558BE02F-E3CA-42C0-8FD0-77C52E21B610Q44667608-9F95C594-CFCA-4D38-982C-42157D5EF6B5Q47362441-7F7F628D-A5EA-47C6-95B7-8C416DBBD5F5Q47418103-5E0CF7AC-FC33-4852-BF28-F3F503939664Q54545281-EDDE97B3-9E75-497A-B6E4-ED3D15B7D60A
P2860
Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lung adenocarcinoma with mixed ...... istochemical characterization.
@ast
Lung adenocarcinoma with mixed ...... istochemical characterization.
@en
Lung adenocarcinoma with mixed ...... istochemical characterization.
@nl
type
label
Lung adenocarcinoma with mixed ...... istochemical characterization.
@ast
Lung adenocarcinoma with mixed ...... istochemical characterization.
@en
Lung adenocarcinoma with mixed ...... istochemical characterization.
@nl
prefLabel
Lung adenocarcinoma with mixed ...... istochemical characterization.
@ast
Lung adenocarcinoma with mixed ...... istochemical characterization.
@en
Lung adenocarcinoma with mixed ...... istochemical characterization.
@nl
P2093
P1476
Lung adenocarcinoma with mixed ...... istochemical characterization.
@en
P2093
Arafumi Maeshima
Hiroshi Terasaki
Hisao Asamura
Naofumi Hayabuchi
Setsuo Hirohashi
Tesshi Yamada
Toshiro Niki
Yoshihiro Matsuno
P304
P356
10.1097/00000478-200307000-00009
P407
P577
2003-07-01T00:00:00Z